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Quantum dots (QDs) are promising nanomaterials due to their unique photophysical properties. For them to
be useful in biological applications, the particle surface generally needs to be conjugated to biological
molecules, such as antibodies. In this study, we screened CdTe/CdS QD-binding peptides from a phage
display library as linkers for simple and bio-friendly QD modification. Among five QD-binding peptide
candidates, a series of truncated peptides designed from two high-affinity peptides were subjected to an
array-based binding assay with QDs to assess their functional core sequences and characteristics. Linking
these isolated, shortened peptides (PWSLNR and SGVYK) with an antibody-binding peptide (NKFRGKYK)
created dual-functional peptides that are capable of QD surface functionalisation by antibodies.
Consequently, the dual-functional peptides could mediate anti-CD9 antibody functionalisation onto CdTe/
CdS QD surface; CD9 protein imaging of cancer cells was also demonstrated. Our proposed peptides offer
an effective vehicle for QD surface functionalisation in biological applications.Introduction
Quantum dots (QDs) are nanoscale luminescent semiconductor
crystals with diameters in the range of 1–20 nm.1 QDs have
attracted much attention because of their unique electronic and
photophysical properties,2 leading to a wide range of applica-
tions, such as in solar cells,3 sensing,4 therapy,5 and imaging.6
In particular, QDs are superior to common organic and bio-
logical uorophores (e.g., uorescein, green uorescent
protein) in terms of their broad absorption spectrum and
excellent photostability.7,8 For the majority of QD-based bio-
logical applications, the materials must be coupled to func-
tional biological molecules (e.g., antibodies, proteins).9,10
Conventional QD functionalisation with biological molecules is
occurred via covalent and non-covalent interactions, and each
method has some drawbacks.11 For example, covalent cross-
links, such as 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC) coupling, require additional chemicalineering, Tokyo Institute of Technology,
-8552, Japan. E-mail: okochi.m.aa@m.
y of Leeds, Leeds, LS2 9JT, UK
rsity of Science and Technology (NTNU),
tion (ESI) available. See DOI:
ly to this work.
3reagents, as well as several preparation steps, and may decrease
photoluminescence yield.12,13 Non-covalent bonds, such as
electrostatic force, also can cause non-specic and unstable
conjugates.14,15
Peptides are increasingly being used as recognition probes
for both organic and inorganic molecules owing to several
reasons, including their small molecular size and good
stability.16,17 Because peptides can be chemically synthesised in
large batch scales, many functional peptides have been
discovered from rational and systematic studies for a wide
range of applications (e.g., targeting, sensing, imaging).18–20
Importantly for the study of nanoparticle functionalisation,
solid-binding peptides can bind or recognise material surfaces
and offer simple and bio-friendly alternatives to conventional
surface modication techniques.21,22 So far, a few peptides have
been reported to possess the capacity to bind to QDs based on
histidine (His or H)-metal affinity.23,24 These His-rich peptides
have the potential to bind to QD surfaces; however, they are
limited to ZnS-shelled QDs.23,24 Since CdTe/CdS core/shell QDs
with high quantum yield can be aqueously synthesised, this QD
type is one of the widely used QDs for biological uorescence
probes.25 Despite its potent material, no peptide binders to
CdTe/CdS QDs have been reported up to date.
Herein, we explored CdTe/CdS QD-binding peptides from
a phage display peptide library. Subsequently, re-conrmation
of the binding between screened peptides and QDs, evalua-
tion of truncated peptides, and determination of the dissocia-
tion constant (KD) were investigated using the peptide arrayThis journal is © The Royal Society of Chemistry 2020
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View Article Onlinetechnique, a method for customising peptide synthesis on
a cellulose membrane. To shed light on a potential application
of the QD-binding peptides, they were connected to an
antibody-binding peptide to form dual-functional peptides.
These dual-functional peptides were functionally evaluated by
surface plasmon resonance (SPR) and were applied to direct
QD-antibody bioconjugation for immunouorescence imaging
without additional chemicals. These CdTe/CdS QD binding
peptides provide a way for simple, effective, and bio-friendly
functionalisation of QD surfaces for bio-applications.Results and discussion
Screening of CdTe/CdS QD-binding peptides
Aqueously synthesised, thioglycolic acid (TGA)-capped CdTe/
CdS core/shell QDs had uniform shape, diameters of around
5 nm (mean standard deviation¼ 4.9 2.5 nm, n¼ 118), and
a bright uorescence emission spectrum peak at 600 nm (Fig. 1i
and ii and S1†). In the phage display screening, ve peptide
sequences (P1–P5) were identied from seven plaques as CdTe/
CdS QD-binding peptides (Table 1). P1–P5 exhibited hydrophilic
properties (grand average of hydropathy (GRAVY) < 0), corre-
lating with the hydrophilic layer of TGA. Additionally, P1–P5 all
carried a net negative charge under neutral conditions
(isoelectric point (pI) < 7). In combination with the fact that TGA
also carries a net negative charge under neutral conditions, this
suggested that the peptide–QD interaction is complex, and the
peptide may have an affinity not only with the TGA layer, but
also the CdS surface. Interestingly, P1–P5 had no, or a very low,
proportion of His residue, implying a different binding mech-
anism to that of previously reported His-rich QD-binding
peptides.23,24 To conrm the peptide binding activity to theFig. 1 (i) and (ii) TEM images of prepared CdTe/CdS QDs. (iii) Fluo-
rescence image of peptide array of P1–P6 after binding assay with
CdTe/CdS QD (100 nM). For clarity, the image is presented in negative.
(iv) Spot intensity profile of (iii). Error bars denote the standard devia-
tion of triplicate results.
This journal is © The Royal Society of Chemistry 2020QDs, the binding assay was carried out using a peptide array.
Fig. 1iii displays the results of the binding assay, which
conrmed the binding activity; each peptide spot from P1–P5
displayed strong QD uorescence, while no QD signal was
found for the negative control, peptide P6 (AAAA). Since P2
(TLTSETPWSLNR) and P4 (SGVYKVAYDWQH) gave higher spot
intensities than the others (Fig. 1iv), these sequences were used
for the following experiments.
Characterisation of CdTe/CdS QD-binding peptides
Two peptide candidates (P2 and P4) were subjected to the
peptide array-based truncation assay to identify the key motif
and amino acid for their binding. As shown in Fig. 2 and Table
1, P7 (PWSLNR) and P8 (SGVYK) were the shortest fragments;
they were derived from P2 and P4, respectively, and played a key
role in QD binding. Several truncated peptides derived from P2
(TLTSETPWSLNR) with a short series of amino acids lacking
from the N-terminus (including TPWSLNR, PWSLNR, and
WSLNR) revealed relatively high binding activity, while those
lacking amino acids from the C-terminus showed only weak
binding activity (Fig. 2i). This result indicates that arginine
residue at the C-terminus is crucial to the binding process for
the P2-derived peptides.
On the other hand, peptides derived from P4 (SGVYK-
VAYDWQH) exhibited a more complex binding prole (Fig. 2ii).
All truncated peptides showed gradual decreases in binding
affinity to QDs except P8 (SGVYK). The binding prole appears
to indicate that the N-terminus region is more important for
binding than the C-terminus. To clarify the key motifs and
characterise the binding behaviour of the sequence, we focused
on the comparison of eight peptides comprising ve amino
acids (SGVYK, GVYKV, VYKVA, YKVAY, KVAYD, VAYDW,
AYDWQ, and YDWQH). Four of these peptides (SGVYK, GVYKV,
VYKVA, and YKVAY), which consist of sequences located
towards the N-terminus of P4, exhibited high-binding activity.
These data suggest that the combined sequence of these four
peptides (i.e. SGVYKVAY) is the main contributor to QD
binding, and the partial sequence SGVYK (P8), is the core
region. The two peptides P7 and P8 have a weakly positive
charge. Despite there being more charged peptides in the
evaluated sequences, these two peptides were identied as the
core region for QD binding. This observation suggests that the
peptides' interaction with the QDs is not simple; electrostatic
and other interactions (for instance hydrogen bonding and
hydrophobic interactions) are likely to contribute; further
research is required to understand this.
The KD of P7 and P8, as determined by Hill equation tting,
was around 96.0 and 48.5 nM, respectively (Fig. 3). These results
indicate that the truncated peptides have high affinity to CdTe/
CdS QDs and will be useful for further QD surface
functionalisation.
Dual-functional peptides for QD-antibody bioconjugation
To demonstrate the potential of these peptides for functional-
isation of QDs, the conjugation of another functional peptide
for antibody binding was evaluated. To create the dual-RSC Adv., 2020, 10, 8218–8223 | 8219
Table 1 A list of peptides used in this studya
Peptide Sequence pI GRAVY Note
P1 GDGNSVLKPGNW 5.84 0.908 Screened with 3/7 frequency
P2 TLTSETPWSLNR 5.66 0.842 Screened with 1/7 frequency
P3 YPSSLNINASSF 5.52 0.017 Screened with 1/7 frequency
P4 SGVYKVAYDWQH 6.46 0.717 Screened with 1/7 frequency
P5 SHALQGPEGTAT 5.22 0.617 Screened with 1/7 frequency
P6 AAAA 3.69 1.800 Negative control
P7 PWSLNR 10.18 1.250 Truncated from P2
P8 SGVYK 8.31 0.440 Truncated from P4
P9 NKFRGKYKGGGPWSLNR 11.17 1.606 Dual-functionalised from P7
P10 NKFRGKYKGGGSGVYK 10.30 1.375 Dual-functionalised from P8
a pI and GRAVY were calculated from ProtParam tool (http://web.expasy.org/protparam/).26
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View Article Onlinefunctional peptides (P9 and P10), P7 and P8 were linked with an
antibody fragment crystallisable (Fc) domain-binding peptide
(NKFRGKYK, and KD of 8.9 mM)27,28 using GGG as a linker (Fig. 4i
and Table 1). By quantifying a bound amount from an unbound
excess in an ultra-centrifuged supernatant, the molar binding
ratio of QDs, peptides and antibodies synthesised in this study
was estimated to be 1 : 44 : 4. There was therefore a high ratio of
short-chain peptides that mediated the linkage between QD and
antibody. To further conrm the dual-functionality of P9 andFig. 2 Truncation results after binding assay between peptide array of
truncated sequences with CdTe/CdS QDs. (i) P2 (TLTSETPWSLNR) and
(ii) P4 (SGVYKVAYDWQH). The peptide array of truncated sequences
was synthesised and used in the binding assay with CdTe/CdSQD (100
nM). Original P2 and P4were defined to have a relative spot intensity of
100%.
8220 | RSC Adv., 2020, 10, 8218–8223P10, an SPR assay was conducted through real-time monitoring
of the SPR response, which indicates the mass of analytes
(peptide and QD) bound to a ligand (antibody) on a sensor chip.
An injection of peptide (at time t ¼ 70 s) and then QDs (t ¼ 560
s) over the antibody-immobilised sensor chip (Fig. S2†) led to
increases in SPR response (Fig. 4ii). Small peptides caused
a slight increase in the SPR response, while the relatively large
QDs caused a greater increase, corresponding to the difference
in their sizes (Fig. 4ii). It illustrates that P9 and P10 have the
dual-functionality of binding to QDs as well as antibodies. The
QD quenching was also investigated by comparing the uores-
cence emission spectrum. As the result of antibody function-
alisation, a slight decrease (about 20%) in uorescence
emission peak at 600 nm was observed (Fig. S3†). This result
showed that the antibody was immobilised on the QD surface,
resulting in the change of surface state and the uorescence
reduction.
To verify the potential of the dual-functional peptide func-
tionalised QDs, these nanomaterials were applied in the
imaging of CD9, a membrane protein linked to the stage andFig. 3 Plot of spot fluorescence intensity against QD concentration
for KD determination. The peptide arrays of P7 (PWSLNR) and P8
(SGVYK) were synthesised and used in binding assays with CdTe/CdS
QDs at different concentrations (0–200 nM). The solid lines are Hill
equation-fitted curves. Error bars indicate the standard deviation of
triplicate results.
This journal is © The Royal Society of Chemistry 2020
Fig. 4 (i) Schematic illustration of QD surface modification using the
dual-functional peptide. (ii) SPR sensorgram from a CD9 antibody-
immobilised sensor chip when flowed with dual-functional peptides
(70 s) and CdTe/CdS QDs (560 s). (iii) CD9 imaging of MDA-MB-231
cancer cells using (a and b) dual-functional peptides (P9 and P10), (c)
a commercial secondary antibody, and (d) a negative control peptide
(P6). Inserts are overlays of brightfield and fluorescence images.
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View Article Onlinemetastasis of cancer cells,29 on xed MDA-MB-231 cancer cells.
P9 and P10-mediated QD-antibody conjugates provided similar
CD9 immuno-images to commercial secondary antibodies
conjugated with Alexa Fluor 568, whereas poly-alanine P6, the
negative control, gave only a weak uorescent image (Fig. 4iii).
Although the quenching was weakly observed by the antibody
immobilisation (Fig. S3†), the uorescence characteristic wasThis journal is © The Royal Society of Chemistry 2020still suitable for the imaging application (Fig. 4iii). This nding
shows that P9 and P10 can be used for simple conjugation of
CdTe/CdS QDs to CD9 antibodies for use in bioimaging. Taken
together, the QD-binding peptides can be integrated with other
functional molecules to modify or functionalise QDs.
Conclusions
Discovery of high-affinity peptide binders to CdTe/CdS QDs was
accomplished using a phage display peptide library and
a peptide array, providing a new tool for QD surface engi-
neering. Dual-functional peptides binding to CdTe/CdS QDs
and antibodies' Fc-regions were designed and applied to ach-
ieve a reagent-free, one-step QD-antibody conjugation. This
alternative and simple strategy for construction of antibody-
functionalised QDs by using a dual-functionality peptide
would be a powerful tool for nanomaterial surface functionali-
sation for various biotechnological applications such as
biosensors, bioimaging and therapy.
Experimental
QD preparation
TGA-capped CdTe/CdS core/shell QDs were prepared with
a similar method to an earlier work.25 The CdTe core was grown
by reuxing a solution of Cd(ClO4)2 and TGA (molar ratio of
1 : 1.3), which was introduced with H2Te gas and deoxygenated
by N2 gas, at 100 C for 2 h. To grow the CdS core, thiourea
(CH4N2S) was added to the core QD dispersion before the
mixture was further reuxed overnight. QDs were cleaned by
adding two parts of isopropanol to one part aqueous QD solu-
tion and agitating. The dispersion was then centrifuged for 5
min at 3000 g to produce a pellet. The supernatant was decanted
and the QDs were then dispersed in ultrapure water (Direct-Q 3
UV-R; Millipore Co., USA) by sonication.
Phage display screening
The Ph.D.™-12 Phage Display Peptide Library Kit (New England
Biolabs, USA) was used according to its user guide. The peptide
library solution was diluted with TBST (50 mM Tris–HCl pH 7.5,
150 mM NaCl, 0.1% v/v Tween-20) and incubated with CdTe/
CdS QDs for 1 h. NaCl solution (2 M) was added to the
mixture before centrifuging (4 C, 4000 g, 2 min) to remove the
unbound phages. The QD-bound phages were washed twice
with TBST, eluted by glycine–HCl (pH 2.2, 0.2 M, 20 min), and
neutralised with Tris–HCl (pH 9.1). Then, the eluted phages
were amplied and counted for the next round of biopanning.
The biopanning was repeated three times, followed by DNA
sequence analysis (7 clones).
Preparation of peptide array
The peptide array was prepared using Fmoc chemistry and
a peptide auto-spotter (MultiPep RSi; Intavis AG, Germany) as
described in previous work.30 In each elongation, the Fmoc
group at the N-terminus was rst deprotected by 20% piperi-
dine in N,N-dimethylformamide (DMF). Next, Fmoc amino acidRSC Adv., 2020, 10, 8218–8223 | 8221
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View Article Onlineat 0.5 M (Watanabe chemical, Japan) was activated by 1.1 M
hydroxybenzotriazole and 1.1 M N,N0-diisopropylcarbodiimide
and spotted on a membrane (grade 542; Whatman, UK). Prior to
use, side chain-protecting groups were deprotected using
a mixture of ultrapure water, triisopropylsilane and triuoro-
acetic acid (2 : 3 : 95), followed by washing with dichloro-
methane, DMF, ethanol and phosphate-buffered saline (PBS,
pH 7.4), respectively.
Binding assay using peptide array
The peptide array was submerged into CdTe/CdS QD solution in
ultrapure water for 2 h at room temperature with slow shaking
ahead of washing with ultrapure water. The peptide array was
scanned by a uorescence imager (Typhoon FLA 9500; GE
healthcare, Sweden) and spot intensity was quantied by Image
Quant soware (GE healthcare).
Evaluation of binding ratio
Peptide powder (Sigma-Aldrich Inc., USA), diluted with TBS to
155 mM, was incubated with CdTe/CdS QDs (0.15 mM, 25 C, 1 h)
and ultra-centrifuged (25 C, 102 000g, 5 h) to collect peptide-
conjugated QDs. FITC-conjugated anti-IgG (H+L) antibodies
(B12113C; Funakoshi, Japan) at 0.5 mMwere incubated with the
peptide-QD conjugate (25 C, 1 h) and ultra-centrifuged (25 C,
435 680g, 1 h) to collect antibody-functionalised QDs. To esti-
mate the binding ratio, the excess peptides and antibodies in
ultra-centrifuged supernatants were quantied by high perfor-
mance liquid chromatography (TSKgel ODS-100Z column,
214 nm absorbance detection) and a uorescence microplate
reader, respectively.
SPR
The CD9 antibody solution (ab92726; Abcam, UK), diluted to 4
mM with acetate buffer (10 mM sodium acetate, pH 5.5), was
immobilised as a ligand onto a CM5 sensor chip using the
amine coupling kit in the SPR system (Biacore X100 Plus
Package; GE healthcare). Peptide (44 mM) and CdTe/CdS QDs (1
mM) as analytes were subsequently owed over the immobilised
surface. The running buffer was HBS-EP (10 mMHEPES pH 7.4,
150 mM NaCl, 3 mM EDTA, 0.005% v/v surfactant P20) and the
regenerating solution was 10 mM glycine–HCl at pH 2.0.
CD9 imaging
MDA-MB-231 human breast cancer cells (ATCC® HTB-26TM;
American type culture collection, USA) were cultured in a 96-
well plate using Dulbecco's modied Eagle's medium with 10%
fetal bovine serum (Life technologies, USA) at 37 C under 5%
CO2 conditions in a humidied atmosphere. Aer a 24 h
culture, cells were xed with 4% formaldehyde and blocked
with 2% bovine serum albumin. CD9 antibody (50 nM in PBS)
was added to the well for 1 h at room temperature. Peptide
(550 nM in PBS) was added to the well for 45 min at room
temperature. CdTe/CdS QDs (12.5 nM in PBS) was added to the
well for 15 min at room temperature. For a positive control
result, Alexa Fluor® 568 Goat Anti-Rabbit (IgG) secondary8222 | RSC Adv., 2020, 10, 8218–8223antibody (ab175471; Abcam) at 50 nM was added to the well for
1 h at room temperature instead of peptide and QDs. Aer each
addition, the solutions were removed, and the cells were
washed in triplicate with PBS. The cells were observed under
uorescence microscope (DMi8; Leica Camera AG, Germany).Conflicts of interest
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